Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In Belgium
This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand how people respond to the medication LY2140023 in practice and what may need to be adjusted.
In BelgiumThis study is completed in Belgium, in Germany, and in Poland. It is testing efficacy of Intravenous Esketamine for treatment-resistant depression.
In BelgiumThis study is completed in Belgium. It is testing intranasal Esketamine for treatment-resistant depression.
In BelgiumThis study is completed in Belgium, in Germany, in Sweden, .... It is testing Once Daily and Twice Daily Doses of JNJ-37822681 for Schizophrenia.
In Belgium
This study is completed in Belgium. It is testing impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) for Depression.
In BelgiumThis study is completed in the United Kingdom, in Belgium, in Czechia, .... It is testing Seltorexant 20 mg for Depression.
In BelgiumThis study is completed in France, in Belgium, in Hungary, .... It is testing 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine for Depression.
In BelgiumThis summary needs review. Please check the official study record and contact the research team for details.
In BelgiumThis study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
Remote / onlineThis study is completed in Belgium, in Argentina, in Austria, .... It focuses on depression.
In BelgiumThis study is completed in Belgium, in Argentina, in Bulgaria, .... It focuses on depression.
In BelgiumHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.